Documents
Application Sponsors
Marketing Status
| Prescription | 001 |
| Prescription | 002 |
| Discontinued | 003 |
| Discontinued | 004 |
| Discontinued | 005 |
Application Products
| 001 | INJECTABLE;INJECTION | 76.9% | 1 | ULTRAVIST 370 | IOPROMIDE |
| 002 | INJECTABLE;INJECTION | 62.3% | 1 | ULTRAVIST 300 | IOPROMIDE |
| 003 | INJECTABLE;INJECTION | 49.9% | 1 | ULTRAVIST 240 | IOPROMIDE |
| 004 | INJECTABLE;INJECTION | 31.2% | 1 | ULTRAVIST 150 | IOPROMIDE |
| 005 | INJECTABLE;INJECTION | 62.3% | 1 | ULTRAVIST 300 IN PLASTIC CONTAINER | IOPROMIDE |
FDA Submissions
| TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1995-05-10 | STANDARD |
| EFFICACY; Efficacy | SUPPL | 2 | AP | 1997-07-23 | UNKNOWN |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1997-06-05 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1998-11-03 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 1998-11-25 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1999-12-27 | STANDARD |
| LABELING; Labeling | SUPPL | 8 | AP | 2003-04-25 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2000-09-27 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 2000-10-24 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 2001-01-04 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 12 | AP | 2001-11-05 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 13 | AP | 2002-04-11 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 14 | AP | 2002-10-30 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2004-03-12 | STANDARD |
| LABELING; Labeling | SUPPL | 22 | AP | 2005-08-12 | STANDARD |
| LABELING; Labeling | SUPPL | 27 | AP | 2007-08-31 | STANDARD |
| EFFICACY; Efficacy | SUPPL | 33 | AP | 2009-12-30 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 35 | AP | 2009-11-13 | STANDARD |
| LABELING; Labeling | SUPPL | 36 | AP | 2012-05-02 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 40 | AP | 2013-07-29 | STANDARD |
| LABELING; Labeling | SUPPL | 41 | AP | 2015-07-06 | STANDARD |
| LABELING; Labeling | SUPPL | 42 | AP | 2017-04-05 | STANDARD |
| LABELING; Labeling | SUPPL | 43 | AP | 2017-07-27 | STANDARD |
| LABELING; Labeling | SUPPL | 45 | AP | 2018-04-02 | STANDARD |
| LABELING; Labeling | SUPPL | 46 | AP | 2018-04-24 | STANDARD |
| LABELING; Labeling | SUPPL | 47 | AP | 2019-08-01 | STANDARD |
| LABELING; Labeling | SUPPL | 52 | AP | 2022-02-18 | STANDARD |
Submissions Property Types
| SUPPL | 4 | Null | 0 |
| SUPPL | 5 | Null | 0 |
| SUPPL | 6 | Null | 0 |
| SUPPL | 7 | Null | 0 |
| SUPPL | 9 | Null | 0 |
| SUPPL | 10 | Null | 0 |
| SUPPL | 11 | Null | 0 |
| SUPPL | 12 | Null | 0 |
| SUPPL | 13 | Null | 0 |
| SUPPL | 14 | Null | 0 |
| SUPPL | 18 | Null | 0 |
| SUPPL | 33 | Null | 7 |
| SUPPL | 35 | Null | 0 |
| SUPPL | 36 | Null | 15 |
| SUPPL | 40 | Null | 0 |
| SUPPL | 41 | Null | 15 |
| SUPPL | 42 | Null | 31 |
| SUPPL | 43 | Null | 6 |
| SUPPL | 45 | Null | 15 |
| SUPPL | 46 | Null | 6 |
| SUPPL | 47 | Null | 6 |
| SUPPL | 52 | Null | 7 |
CDER Filings
BAYER HLTHCARE
cder:Array
(
[0] => Array
(
[ApplNo] => 20220
[companyName] => BAYER HLTHCARE
[docInserts] => ["",""]
[products] => [{"drugName":"ULTRAVIST 150","activeIngredients":"IOPROMIDE","strength":"31.2%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"ULTRAVIST 240","activeIngredients":"IOPROMIDE","strength":"49.9%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"ULTRAVIST 300","activeIngredients":"IOPROMIDE","strength":"62.3%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"ULTRAVIST 300 IN PLASTIC CONTAINER","activeIngredients":"IOPROMIDE","strength":"62.3%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"ULTRAVIST 370","activeIngredients":"IOPROMIDE","strength":"76.9%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"02\/18\/2022","submission":"SUPPL-52","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/020220s052,021425s034lbl.pdf\"}]","notes":""},{"actionDate":"08\/01\/2019","submission":"SUPPL-47","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020220s047lbl.pdf\"}]","notes":""},{"actionDate":"04\/24\/2018","submission":"SUPPL-46","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020220s046lbl.pdf\"}]","notes":""},{"actionDate":"04\/02\/2018","submission":"SUPPL-45","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020220s045lbl.pdf\"}]","notes":""},{"actionDate":"07\/27\/2017","submission":"SUPPL-43","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020220s043lbl.pdf\"}]","notes":""},{"actionDate":"04\/05\/2017","submission":"SUPPL-42","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020220s042lbl.pdf\"}]","notes":""},{"actionDate":"04\/05\/2017","submission":"SUPPL-42","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020220Orig1s042,021425Orig1s026ltr.pdf\"}]","notes":""},{"actionDate":"07\/06\/2015","submission":"SUPPL-41","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020220s041,021425s024lbl.pdf\"}]","notes":""},{"actionDate":"05\/02\/2012","submission":"SUPPL-36","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020220s036lbl.pdf\"}]","notes":""},{"actionDate":"12\/30\/2009","submission":"SUPPL-33","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020220s033lbl.pdf\"}]","notes":""},{"actionDate":"08\/31\/2007","submission":"SUPPL-27","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020220s027lbl.pdf\"}]","notes":""},{"actionDate":"03\/12\/2004","submission":"SUPPL-18","supplementCategories":"Manufacturing (CMC)-Packaging","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20220scp018_ultravist_lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"ULTRAVIST 150","submission":"IOPROMIDE","actionType":"31.2%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"ULTRAVIST 240","submission":"IOPROMIDE","actionType":"49.9%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"ULTRAVIST 300","submission":"IOPROMIDE","actionType":"62.3%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ULTRAVIST 300 IN PLASTIC CONTAINER","submission":"IOPROMIDE","actionType":"62.3%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"ULTRAVIST 370","submission":"IOPROMIDE","actionType":"76.9%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2022-02-18
)
)